Study of Accessory Lacrimal Gland and Precursor Cell Biology

副泪腺及前体细胞生物学研究

基本信息

  • 批准号:
    9044784
  • 负责人:
  • 金额:
    $ 23.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a proposal for a K08 Mentored Clinical Scientist Career Development Award to train Dr. Vinay Kumar Aakalu. The primary goal of this application is to serve as a basis for training Dr. Aakalu in the critical skills necessary to deveop into an independent scientific investigator focused on lacrimal cell and precursor cell biology. The specific aims of the proposed educational program are the performance of 1) graduate level cell, molecular, stem cell biology and basic translational/clinical trial course work at the University of Illinois at Chicago 2) basic scientific investigations in accessory lacrimal cell and stem cell biology under the guidance of an experienced four person mentoring committee 3) seminar and conference participation at the University of Illinois and outside the University of Illinois. The mentoring committee is made up of experts in stem cell, ocular, molecular cell biology and translational research. Each mentor is well experienced in training clinician- scientists. The mentoring committee will be focused on guiding Dr. Aakalu in the development of research skills, analytical thinking and the ethical performance of basic and translational research. The overarching research goals of the proposal are to develop a better understanding of accessory lacrimal cell biology and to identify and isolate precursor cells from this tissue. Th specific aims of the project are to: 1. Develop a better understanding of ALG distribution, growth requirements, and changes with patient characteristics. 1a. A three dimensional map of the cadaveric human orbit will be constructed to determine the location of ALG tissue throughout the ocular surface as a basis for rational harvesting decisions. 1b. Characterize ALG tissue in human surgical specimens and relate the robustness or histopathologic changes in these tissues to relevant patient characteristics (age, gender, race, hormonal status). 1c. Develop ALG cultures from human surgical specimens to better understand requirements for cell survival and expansion. 2. Establish the presence of precursor cells in ALG tissue and isolate and characterize these precursor cells. 2a. Identify precursor marker positive ALG cells and determine a signature marker pattern using human specimens and immunohistochemistry on tissue microarrays. 2b. Isolate precursor candidate cells utilizing fluorescence cell sorting and determine if changes in precursor candidate cell populations are noted with different patient characteristics. 2c. Determine if precursor candidate cells isolated have stem cell properties. 2d. Establish cultures from precursor candidates and determine if these cultures can produce functional ALG cells.
描述(由申请人提供):这是一份K 08指导临床科学家职业发展奖的提案,旨在培训Vinay Kumar Aakalu博士。该应用程序的主要目标是作为培训Aakalu博士所需的关键技能的基础,以发展成为专注于泪腺细胞和前体细胞生物学的独立科学研究者。拟议的教育计划的具体目标是1)研究生水平的细胞,分子,干细胞生物学和基本的转化/临床试验课程工作在伊利诺伊大学芝加哥2)在副泪腺细胞的基础科学研究和 在一个经验丰富的四人指导委员会的指导下进行干细胞生物学的研究。3)参加伊利诺伊大学和伊利诺伊大学以外的研讨会和会议。指导委员会由干细胞、眼科、分子细胞生物学和转化研究领域的专家组成。每位导师在培训临床医生-科学家方面经验丰富。指导委员会将专注于指导Aakalu博士发展研究技能,分析思维以及基础和转化研究的道德表现。该提案的总体研究目标是更好地了解副泪腺细胞生物学,并从该组织中识别和分离前体细胞。该项目的具体目标是:1。更好地了解ALG的分布、生长要求以及患者特征的变化。1a.将构建尸体人眼眶的三维图,以确定ALG组织在整个眼表中的位置,作为合理采集决策的基础。1b.表征人体手术标本中的ALG组织,并将这些组织中的稳健性或组织病理学变化与相关患者特征(年龄、性别、种族、激素状态)相关联。1c.从人类手术标本中开发ALG培养物,以更好地了解细胞存活和扩增的要求。2.建立ALG组织中前体细胞的存在,并分离和表征这些前体细胞。2a.鉴定前体标志物阳性ALG细胞,并使用人类标本和组织微阵列上的免疫组织化学确定特征标志物模式。2b.利用荧光细胞分选分离前体候选细胞,并确定前体候选细胞群的变化是否与不同的患者特征有关。2c.确定分离的前体候选细胞是否具有干细胞特性。2d. 从前体候选者建立培养物,并确定这些培养物是否可以产生功能性ALG细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vinay Aakalu其他文献

Vinay Aakalu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vinay Aakalu', 18)}}的其他基金

Novel Therapeutic Approaches for NPC Disease
鼻咽癌的新治疗方法
  • 批准号:
    10650430
  • 财政年份:
    2022
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Ocular Surface Diseases
眼表疾病的新疗法
  • 批准号:
    10795227
  • 财政年份:
    2019
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Ocular Surface Diseases
眼表疾病的新疗法
  • 批准号:
    10225306
  • 财政年份:
    2019
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Ocular Surface Diseases
眼表疾病的新疗法
  • 批准号:
    9902473
  • 财政年份:
    2019
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Ocular Surface Diseases
眼表疾病的新疗法
  • 批准号:
    10376340
  • 财政年份:
    2019
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Modulation of Innate Immunity in Veteran Related Eye Diseases
调节退伍军人相关眼病先天免疫的新疗法
  • 批准号:
    9562360
  • 财政年份:
    2018
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Modulation of Innate Immunity in Veteran Related Eye Diseases
调节退伍军人相关眼病先天免疫的新疗法
  • 批准号:
    10292904
  • 财政年份:
    2018
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Modulation of Innate Immunity in Veteran Related Eye Diseases
调节退伍军人相关眼病先天免疫的新疗法
  • 批准号:
    10046282
  • 财政年份:
    2018
  • 资助金额:
    $ 23.64万
  • 项目类别:
Novel Treatments for Modulation of Innate Immunity in Veteran Related Eye Diseases
调节退伍军人相关眼病先天免疫的新疗法
  • 批准号:
    10516064
  • 财政年份:
    2018
  • 资助金额:
    $ 23.64万
  • 项目类别:
Study of Accessory Lacrimal Gland and Precursor Cell Biology
副泪腺及前体细胞生物学研究
  • 批准号:
    8679183
  • 财政年份:
    2014
  • 资助金额:
    $ 23.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了